nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activated protein C suppresses osteoclast differentiation via endothelial protein C receptor, protease-activated receptor-1, sphingosine 1-phosphate receptor, and apolipoprotein E receptor 2
|
Yoshida, Kakunoshin |
|
2018 |
163 |
C |
p. 30-40 |
artikel |
2 |
Anticoagulant drug choice in patients who have had bariatric surgery – Presently, DOACs are not the preferred choice
|
Moll, Stephan |
|
2018 |
163 |
C |
p. 196-199 |
artikel |
3 |
Argatroban dosing in obesity
|
Elagizi, Stephanie |
|
2018 |
163 |
C |
p. 60-63 |
artikel |
4 |
Assessment of two contact activation reagents for the diagnosis of congenital factor XI deficiency
|
Salloum-Asfar, Salam |
|
2018 |
163 |
C |
p. 64-70 |
artikel |
5 |
Clinical manifestations and imaging tools in the diagnosis of splanchnic and cerebral vein thromboses
|
Riva, Nicoletta |
|
2018 |
163 |
C |
p. 252-259 |
artikel |
6 |
CREM-transgene mice: An animal model of atrial fibrillation and thrombogenesis
|
Bukowska, A. |
|
2018 |
163 |
C |
p. 172-179 |
artikel |
7 |
Diagnosing upper extremity deep vein thrombosis with non-contrast-enhanced Magnetic Resonance Direct Thrombus Imaging: A pilot study
|
Dronkers, C.E.A. |
|
2018 |
163 |
C |
p. 47-50 |
artikel |
8 |
Diagnosis and Exclusion of Pulmonary Embolism
|
Kline, Jeffrey A. |
|
2018 |
163 |
C |
p. 207-220 |
artikel |
9 |
Diagnosis of deep-vein thrombosis
|
Bernardi, Enrico |
|
2018 |
163 |
C |
p. 201-206 |
artikel |
10 |
Diagnosis of recurrent venous thromboembolism
|
Barco, Stefano |
|
2018 |
163 |
C |
p. 229-235 |
artikel |
11 |
Diagnosis of venous thromboembolism in pregnancy
|
Chan, Wee-Shian |
|
2018 |
163 |
C |
p. 221-228 |
artikel |
12 |
Editorial Board
|
|
|
2018 |
163 |
C |
p. IFC |
artikel |
13 |
Effectiveness and safety of outpatient rivaroxaban versus warfarin for treatment of venous thromboembolism in patients with a known primary hypercoagulable state
|
Coleman, Craig I. |
|
2018 |
163 |
C |
p. 132-137 |
artikel |
14 |
Effect of increased time in the therapeutic range on atrial fibrillation outcomes within a centralized anticoagulation service
|
Phelps, Elise |
|
2018 |
163 |
C |
p. 54-59 |
artikel |
15 |
Endothelial cell functions impaired by interferon in vitro: Insights into the molecular mechanism of thrombotic microangiopathy associated with interferon therapy
|
Jia, Haiyan |
|
2018 |
163 |
C |
p. 105-116 |
artikel |
16 |
Fatal acute disseminated intravascular coagulation as presentation of advanced ALK-positive non-small cell lung cancer: Does oncogene addiction matter?
|
De Giglio, Andrea |
|
2018 |
163 |
C |
p. 51-53 |
artikel |
17 |
Genetic mutations in PEAR1 associated with cardiovascular outcomes in Chinese patients with acute coronary syndrome
|
Nie, Xiao-yan |
|
2018 |
163 |
C |
p. 77-82 |
artikel |
18 |
Heterozygous FGA p.Asp473Ter (fibrinogen Nieuwegein) presenting as antepartum cerebral thrombosis
|
Tajdar, Mercedeh |
|
2018 |
163 |
C |
p. 185-189 |
artikel |
19 |
Impact of non-anticoagulant therapy on patients with sepsis-induced disseminated intravascular coagulation: A multicenter, case-control study
|
Kudo, Daisuke |
|
2018 |
163 |
C |
p. 22-29 |
artikel |
20 |
Impaired plasminogen binding in patients with venous thromboembolism: Association with protein carbonylation
|
Siudut, Jakub |
|
2018 |
163 |
C |
p. 12-18 |
artikel |
21 |
Influence of pre-analytical time and temperature conditions on serum thromboxane B2 levels
|
van Diemen, J.J.K. |
|
2018 |
163 |
C |
p. 1-5 |
artikel |
22 |
Initial strides for invent-VTE: Towards global collaboration to accelerate clinical research in venous thromboembolism
|
Rodger, Marc |
|
2018 |
163 |
C |
p. 128-131 |
artikel |
23 |
Intraplatelet reactive oxygen species (ROS) correlate with the shedding of adhesive receptors, microvesiculation and platelet adhesion to collagen during storage: Does endogenous ROS generation downregulate platelet adhesive function?
|
Ghasemzadeh, Mehran |
|
2018 |
163 |
C |
p. 153-161 |
artikel |
24 |
Laboratory biomarkers for venous thromboembolism risk in patients with hematologic malignancies: A review
|
Samuelson Bannow, B.T. |
|
2018 |
163 |
C |
p. 138-145 |
artikel |
25 |
Low-molecular-weight heparin treatment for portal vein thrombosis in liver cirrhosis: Efficacy and the risk of hemorrhagic complications
|
Kwon, Jihyun |
|
2018 |
163 |
C |
p. 71-76 |
artikel |
26 |
Management of direct oral anticoagulant associated bleeding: Results of a multinational survey
|
Shaw, Joseph R. |
|
2018 |
163 |
C |
p. 19-21 |
artikel |
27 |
Modern diagnosis of chronic thromboembolic pulmonary hypertension
|
Kharat, Aileen |
|
2018 |
163 |
C |
p. 260-265 |
artikel |
28 |
New developments and future challenges of nuclear medicine and molecular imaging for pulmonary embolism
|
Le Roux, Pierre-Yves |
|
2018 |
163 |
C |
p. 236-241 |
artikel |
29 |
Occult cancer detection in patients with hemostatic disorder and venous thromboembolism
|
Husseinzadeh, Holleh |
|
2018 |
163 |
C |
p. 242-245 |
artikel |
30 |
Point of Care Testing (POCT) to assess drug concentration in patients treated with non-vitamin K antagonist oral anticoagulants (NOACs)
|
Padayattil Jose, S. |
|
2018 |
163 |
C |
p. 100-104 |
artikel |
31 |
Predicting the risk of recurrent venous thromboembolism in patients with cancer: A prospective cohort study
|
van Es, Nick |
|
2018 |
163 |
C |
p. 41-46 |
artikel |
32 |
Preface to Diagnosis of venous thromboembolism
|
Le Gal, Grégoire |
|
2018 |
163 |
C |
p. 200 |
artikel |
33 |
Prognostic significance of electrocardiogram at presentation in patients with pulmonary embolism of different severity
|
Casazza, Franco |
|
2018 |
163 |
C |
p. 123-127 |
artikel |
34 |
Prophylactic doses of low-molecular weight heparin as periprocedural bridging therapy in mechanical heart valve patients
|
Hjellström, Line |
|
2018 |
163 |
C |
p. 180-184 |
artikel |
35 |
Pulmonary embolism severity assessment and prognostication
|
Barrios, Deisy |
|
2018 |
163 |
C |
p. 246-251 |
artikel |
36 |
Rivaroxaban versus warfarin for the prevention of post-thrombotic syndrome
|
Utne, K.K. |
|
2018 |
163 |
C |
p. 6-11 |
artikel |
37 |
Routine clinical anti-platelet agents have limited efficacy in modulating hypershear-mediated platelet activation associated with mechanical circulatory support
|
Valerio, Lorenzo |
|
2018 |
163 |
C |
p. 162-171 |
artikel |
38 |
Simple method for removing DOACs from plasma samples
|
Exner, T. |
|
2018 |
163 |
C |
p. 117-122 |
artikel |
39 |
The effect of bariatric surgery on direct-acting oral anticoagulant drug levels
|
Rottenstreich, Amihai |
|
2018 |
163 |
C |
p. 190-195 |
artikel |
40 |
The lectin pathway and coagulation in lung cancer patients undergoing lobectomy – A randomised controlled trial
|
Larsen, Julie Brogaard |
|
2018 |
163 |
C |
p. 92-99 |
artikel |
41 |
Transition of care for patients with venous thromboembolism: Rationale, design and implementation of a quality intervention project conducted at American Thrombosis and Hemostasis Network (ATHN) affiliated sites
|
Jaffray, Julie |
|
2018 |
163 |
C |
p. 146-152 |
artikel |
42 |
What have we learned from real-world NOAC studies in venous thromboembolism treatment?
|
Beyer-Westendorf, Jan |
|
2018 |
163 |
C |
p. 83-91 |
artikel |